Nov 13 (Reuters) - Novo Nordisk and Eli Lilly ( LLY )

do not have a weight-loss drug partnership with

telehealth website Mangoceuticals Inc ( MGRX ), spokespeople for

both companies said, rejecting a press release issued by the

company on Thursday that described arrangements with the two

leading drugmakers.

Spokespeople for both companies said in emails to Reuters

that they had no special arrangements with the company.

Mangoceuticals ( MGRX ) did not respond to request for comment.